Media

By Aurélien BERNARD Canadian cannabis producer Canopy Growth announced a significant improvement in its financial results for the fourth quarter of fiscal year 2026, driven by strong growth in both the medical cannabis sector and its international operations. These results suggest that the restructuring efforts the company has been undertaking for several years may finally be starting to pay off.

Watch Luc Mongeau, CEO of Canopy Growth discuss the company’s fiscal Q4 and full-year 2026 earnings.

Luc Mongeau, CEO of Canopy Growth, joins BNN Bloomberg to discuss the company's Q4 earnings as well as the outlook for the cannabis industry.

Canopy Growth Corp. announced the relaunch of the Tweed brand in the German medical market, alongside the introduction of three cannabis strains developed by MTL Cannabis Corp. (MTL), a wholly-owned subsidiary of the company....

Canopy Growth today announced Deelish ("DEE-LISH"), a new cannabis brand "built for the everyday consumer with an everyday price." Deelish enters the market with flower testing at 27%-33% THC and pre-rolls at 26%-32% THC. The brand will rotate its genetic lineup regularly, giving consumers access to a range of cultivars over time....

Canopy Growth has announced a refresh of Tweed, one of Canada's most recognizable cannabis brands, alongside a national summer campaign, "There's a Tweed for That."

Luc Mongeau, CEO of Canopy Growth, joins BNN Bloomberg to discuss the company's shift towards the medical market....

Canopy Growth Corporation has completed its previously announced arrangement to acquire MTL Cannabis Corp. This deal involved Canopy acquiring all of the issued and outstanding common shares of MTL, with the combined company establishing Canada’s leading medical cannabis platform by revenue.

Canopy Growth has announced that it has entered into a series of transactions to recapitalize its balance sheet and extend the maturity dates of all outstanding indebtedness to January 2031 at the earliest. At the conclusion of these transactions, Canopy Growth is expected to have cash on hand of approximately C$425 million, providing additional flexibility to support the Company’s long-term priorities.

As part of an announcement on Thursday from the Oval Office, President Trump also called on the US Congress to update the definition of hemp-derived cannabinoid products to allow access to “full-spectrum CBD products....

Canopy Growth announced Monday that it has agreed to acquire Québec-based MTL Cannabis in a transaction valued at approximately $125 million on a fully diluted equity basis, a deal the company says will significantly strengthen its position in Canada’s medical marijuana market while expanding high-quality flower supply for both domestic and international markets....

Canopy Growth to buy MTL Cannabis in deal valued at $125 million Luc Mongeau, CEO of Canopy Growth, joins BNN Bloomberg to discuss the company's arrangement agreement to acquire MTL Cannabis